Blog / Archives
M&A Theme Continues To Boost Biotech Stocks
M&A Boosts Biotech Stocks For Third Day Gilead Sciences (GILD) and bluebird bio (BLUE) Both Soar Today Biotech Sector Back to 2017 Highs The prospect of more M&A boosts biotech stocks for a...
At Last A Deal Sparks Biotech Rally: Gilead Buys Kite for $11.9B+…Update-1
Update-11:30am Aug 28 Green Screen in Biotech Especially CAR-T Plays (BLUE,CLLS,JUNO) NASDAQ up a tad 0.21%, but broad market flattish. Biotech Deal Boosts ETFs: FBT up 2.71%, IBB up 1.53%, XBI up...
Vacation ’till August 26 Unless Unusual Vol
Not Much To Report-Vacation Doldrums Momentum Has Eased a Tad Investors Expecting Growth from Large Caps and M&A from Mid-Caps. We are on vacation until August 25 unless big news and volatility...
Biotech Snapshot on a Rally Day…Update-2
8/10 Red Screen in the Morning We cautioned on XBI at $78 on 7/31 and today it broke through support at $75 to $74.70. ======= 8/9 Update After Close: A Bit of Caution after Trump's "Fire and Fury"...
Large Cap Biopharma Earnings Boost Stocks: Update 8/1/17
Rayno Large Cap Biopharma Earnings Summary 8/1/17 Biotech Stocks Hit Highs in Mid-July up 18%, 30% on XBI (Click on "urls" below for Company Press Release) All the large cap biopharmaceutical...
Rayno BioBeat #4: Biotechs Weaken on Profit Taking…Update-2
Update-2 7/31 After Close: Biotechs Remain Weak But No Sell Signal As we track the XBI over the past 5 days we are about 3.2% off highs from $82 down to $78.17. Although the XBI has been our top ETF...
ACA: Uncertainty Remains After Healthcare Bill Failure But Stocks Get a Second Wind…Update-1
Update-1... JY 19...Biotech and Healthcare Stocks Continue to Rally IBB breaks through top to $322.92 up 21.68% YTD; XBI up 1.34% today 35.4% YTD; XLV up 17.6% YTD. Rayno Life Science top winners...
Hot Fun in the Summertime: NYC Hits 92 degrees;Healthcare Plan Draft Out
Update after close 7/13: Health Care draft bill appears to have stabilized biotech despite opposition. ETFs end in green but XLV is flat. More analysis is coming tomorrow. ========= It's Vacation...
2017 Life Science Review #1: Big Biotech Gains for First Half
Big Biotech Gains for Stocks in First Half Rayno Life Science Picks Top Winners YTD: Foundation Medicine (FMI) up 124.6%, bluebird bio (BLUE) up 70.26%, XBI up 20.9%. Large cap winners since...
Sector Rotation or Another Tech Wreck?
Tech Wreck Part 2? Or Just Profit Taking. Sector Rotation Away from Large Cap Growth (QQQ) to Value (XLF) Volatility Returns Tech and biotech stocks were hit from sector rotation with the NASDAQ...
